Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Targets & Mechanisms

Adhesion targets emerge at ASH 2018

Emerging science on adhesion molecules, RNA-binding proteins and more at ASH 2018

November 30, 2018 4:21 AM UTC

The next wave of targets in blood cancers and hematology will come from adhesion molecules, innate immune cells and regulators of gene expression, according to BioCentury’s analysis of emerging targets at ASH 2018.

BioCentury’s analysis of abstracts released ahead of this year’s meeting of the American Society of Hematology (ASH) identifies 19 new and 58 emerging targets (see “Table: New Targets at ASH 2018” and “Figure: Emerging Functions”). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article